Delta Lloyd’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-108,837
Closed -$2.59M 450
2016
Q3
$2.59M Buy
108,837
+16,738
+18% +$399K 0.08% 199
2016
Q2
$2.15M Hold
92,099
0.07% 208
2016
Q1
$1.73M Sell
92,099
-3,675
-4% -$64.6K 0.06% 249
2015
Q4
$1.77M Buy
95,774
+3,198
+3% +$57.3K 0.06% 230
2015
Q3
$1.52M Hold
92,576
0.05% 269
2015
Q2
$1.64M Buy
92,576
+31,786
+52% +$568K 0.05% 254
2015
Q1
$1.08M Buy
60,790
+8,783
+17% +$139K 0.03% 275
2014
Q4
$689K Hold
52,007
0.02% 369
2014
Q3
$614K Hold
52,007
0.01% 370
2014
Q2
$664K Hold
52,007
0.02% 329
2014
Q1
$703K Buy
52,007
+9,688
+23% +$127K 0.02% 291
2013
Q4
$509K Buy
42,319
+9,176
+28% +$108K 0.02% 339
2013
Q3
$389K Hold
33,143
0.01% 381
2013
Q2
$307K Buy
+33,143
New +$281K 0.01% 431

Other funds holding BSX

Delta Lloyd's BSX Position: Q4 2016 in Review

Delta Lloyd sold out of Boston Scientific (BSX) in Q4 2016, closing a stake of 108,837 shares — an estimated $2.59M sold.

Delta Lloyd first reported a position in BSX in Q2 2013 and held it in 14 quarters. The position peaked at $2.59M in Q3 2016. 556 funds tracked by Wall St. Rank hold BSX as of Q4 2016.

  • Delta Lloyd reported no remaining Boston Scientific position as of Q4 2016 after selling out during the quarter.
  • Delta Lloyd sold 108,837 Boston Scientific shares in Q4 2016, an estimated $2.59M.
  • Delta Lloyd first reported a position in Boston Scientific in Q2 2013 and held it in 14 quarters.
  • Delta Lloyd's Boston Scientific position peaked at $2.59M in Q3 2016.
  • 556 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2016.

Based on Delta Lloyd's 13F filing for Q4 2016, filed 2 Feb 2017.